Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of FULC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Fulcrum Therapeutics, Inc. stock price ended at $9.46 on Wednesday, after gaining 3.61%.
(Updated on Mar 27, 2024)

Sell candidate since Mar 20, 2024 Loss -2.87% PDF

The Fulcrum Therapeutics, Inc. stock price gained 3.61% on the last trading day (Wednesday, 27th Mar 2024), rising from $9.13 to $9.46. During the last trading day the stock fluctuated 5.94% from a day low at $9.17 to a day high of $9.72. The price has fallen in 7 of the last 10 days and is down by -16.73% for this period. Volume fell on the last day by -277 thousand shares and in total, 460 thousand shares were bought and sold for approximately $4.35 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $9.20 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 52.35% during the next 3 months and, with a 90% probability hold a price between $14.02 and $19.97 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

FULC Signals & Forecast

Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Fulcrum Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $9.62 and $10.03. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 06, 2024, and so far it has fallen -21.17%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Fulcrum Therapeutics, Inc. stock

Fulcrum Therapeutics, Inc. finds support from accumulated volume at $9.25 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.545 between high and low, or 5.94%. For the last week, the stock has had daily average volatility of 7.18%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (FULC) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Fulcrum Therapeutics, Inc. to open at $9.45, and during the day (based on 14 day Average True Range), to move between $8.70 and $10.22, which gives a possible trading interval of +/-$0.761 (+/-8.05%) up or down from last closing price. If Fulcrum Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 16.09% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $9.25 (2.22%) than the resistance at $10.18 (7.61%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Fulcrum Therapeutics, Inc. stock A Buy?

The Fulcrum Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Fulcrum Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.727 Sell Candidate Unchanged

Predicted Opening Price for Fulcrum Therapeutics, Inc. of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$9.45 ( 0.123%) $9.46

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for FULC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.99 5.64 %
R2 9.79 3.44 %
R1 9.66 2.08 %
Current price: 9.46
Support S1 9.24 -2.32 %
S2 9.11 -3.68 %
S3 8.90 -5.88 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 11.36 20.08 %
R2 11.31 19.56 %
R1 10.18 7.61 %
Current price 9.46
Support S1 9.25 -2.22%
S2 8.95 -5.39%
S3 7.25 -23.36%

FAQ

What is the symbol for Fulcrum Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Fulcrum Therapeutics, Inc. is FULC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Fulcrum Therapeutics, Inc. Stock?
The Fulcrum Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Fulcrum Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Fulcrum Therapeutics, Inc. Stock?
Fulcrum Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Fulcrum Therapeutics, Inc. Stock.

What's the current price of Fulcrum Therapeutics, Inc. Stock?
As of the end of day on the 2024-03-27, the price of an Fulcrum Therapeutics, Inc. (FULC) share was $9.46.

What is the 52-week high and low for Fulcrum Therapeutics, Inc. Stock?
The 52-week high for Fulcrum Therapeutics, Inc. Stock is $13.70 and the 52-week low is $2.25.

What is the market capitalization of Fulcrum Therapeutics, Inc. Stock?
As of the 2024-03-27, the market capitalization of Fulcrum Therapeutics, Inc. is 565.468M.

When is the next earnings date for Fulcrum Therapeutics, Inc.?
The upcoming earnings date for Fulcrum Therapeutics, Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics. Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy; and FTX-6058, an investigational oral fetal hemoglobin inducer for the treatment of sickle cell di... FULC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT